France· FR:62832598
VELSIPITY 2 mg, comprimé pelliculé
A medicinal product containing étrasimod arginine, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉTRASIMOD ARGININE
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930289747plaquette(s) aluminium OPA : polyamide orienté polyéthylène haute densité (PEHD) polyéthylène basse densité (PEBD) papier de 28 comprimé(s)EUR 501.92
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Étrasimod arginine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVELSIPITYPfizer Europe MA EEIG, Bruxelles
- FinlandVelsipityPfizer Europe MA EEIG
- BelgiumVelsipity 2 mgPfizer Europe MA
- IcelandVelsipityPfizer Europe MA EEIG*
- NetherlandsVelsipity 2 mg filmomhulde tabletPfizer Europe MA EEIG
- United StatesVelsipityPfizer Laboratories Div Pfizer Inc
- IrelandVelsipity 2 mg film-coated tabletsPfizer Europe MA EEIG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f503d917-c263-4dd1-9f27-6ffe2e63da57 GET /v1/drugs/f503d917-c263-4dd1-9f27-6ffe2e63da57?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62832598",
"date_amm": "2024-02-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/23/1790",
"substance": "ÉTRASIMOD ARGININE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about étrasimod arginine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.